Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil (Q77995532)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1999

Language	Label	Description	Also known as
English	Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil	scientific article published on 01 August 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D W Miles

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

W H Harris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C E Gillett

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D M Barnes

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

84

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

354-359

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Expression of the c-erbB-2 protein in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

The relationship between prognostic and predictive factors in the management of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

c-erbB-2 oncogene as a prognostic marker in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990820%2984%3A4%3C354%3A%3AAID-IJC4%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19990820)84:4<354::AID-IJC4>3.0.CO;2-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

release_kecmyc2i4vfbbb36anedrocatm

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10404085%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77995532&oldid=1832235648"